Summary
Theranos Inc (Theranos),formerly RealTime Cures, Inc., is a healthcare technology company. It develops all the medical devices including hardware and consumables. The company’s product portfolio includes miniLab devices and Sample Collection Devices (SCD). Theranos’s miniLab is a portable device which is designed to process and analyze very small samples of blood. Its SCD is designed to collect small blood samples from a finger prick into a pair of Nanotainer tubes. The company developed a remote server,  Theranos Virtual Analyzer  which is developed to communicate with the Theranos miniLab through secure wired or wireless connections. Theranos is headquartered in Palo Alto, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.  
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theranos Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
                     
                                   '
                        
Table of Contents
Table of Contents  2
List of Tables  3
List of Figures  3
Theranos Inc Company Overview  4
Theranos Inc Company Snapshot  4
Theranos Inc Pipeline Products and Ongoing Clinical Trials Overview  4
Theranos Inc – Pipeline Analysis Overview  7
Theranos Inc - Key Facts  7
Theranos Inc - Major Products and Services  8
Theranos Inc Pipeline Products by Development Stage  9
Theranos Inc Pipeline Products Overview  11
Ebola Blood Test  11
Ebola Blood Test Product Overview  11
HSV-1 IgG Test - Venous/Capillary  12
HSV-1 IgG Test - Venous/Capillary Product Overview  12
miniLab System  13
miniLab System Product Overview  13
Nanotainer Tubes  14
Nanotainer Tubes Product Overview  14
Sample Collection Device  15
Sample Collection Device Product Overview  15
Theranos HSV-1 IgG Assay - CLIA Waived  16
Product Status  16
Theranos Virtual Analyzer  17
Theranos Virtual Analyzer Product Overview  17
Zika Nucleic Acid-Amplification-Based Assay  18
Zika Nucleic Acid-Amplification-Based Assay Product Overview  18
Theranos Inc - Key Competitors  19
Theranos Inc - Key Employees  20
Theranos Inc - Locations And Subsidiaries  21
Head Office  21
Recent Developments  22
Theranos Inc, Recent Developments  22
Jan 17, 2017: Theranos Announces Engineering Experts Join Company’s New Technology Advisory Board  22
Jan 06, 2017: Theranos Announces Company Re-engineers Operations  23
Dec 12, 2016: Theranos Enhances Executive Ranks  23
Dec 01, 2016: Theranos appoints new board member  24
Oct 05, 2016: An Open Letter From Elizabeth Holmes  24
Aug 25, 2016: Theranos to appeal CMS sanctions  25
Aug 01, 2016: Theranos unveils its diagnostic-testing technologies at American Association for Clinical Chemistry meeting  25
Jul 21, 2016: Theranos names new executives: vice president, regulatory and quality, and chief compliance officer  26
Jul 07, 2016: Theranos Receives Notice of Sanctions from the Centers for Medicare & Medicaid Services  27
May 11, 2016: Theranos Announces Expansion of Board of Directors and New Organizational Structure  28
Appendix  30
Methodology  30
About GlobalData  32
Contact Us  32
Disclaimer  32
List of Tables
Theranos Inc Pipeline Products and Ongoing Clinical Trials Overview  4
Theranos Inc Pipeline Products by Equipment Type  5
Theranos Inc Pipeline Products by Indication  6
Theranos Inc, Key Facts  7
Theranos Inc, Major Products and Services  8
Theranos Inc Number of Pipeline Products by Development Stage  9
Theranos Inc Pipeline Products Summary by Development Stage  10
Ebola Blood Test - Product Status  11
Ebola Blood Test - Product Description  11
HSV-1 IgG Test - Venous/Capillary - Product Status  12
HSV-1 IgG Test - Venous/Capillary - Product Description  12
miniLab System - Product Status  13
miniLab System - Product Description  13
Nanotainer Tubes - Product Status  14
Nanotainer Tubes - Product Description  14
Sample Collection Device - Product Status  15
Sample Collection Device - Product Description  15
Product Status  16
Theranos HSV-1 IgG Assay - CLIA Waived - Product Description  16
Theranos Virtual Analyzer - Product Status  17
Theranos Virtual Analyzer - Product Description  17
Zika Nucleic Acid-Amplification-Based Assay - Product Status  18
Zika Nucleic Acid-Amplification-Based Assay - Product Description  18
Theranos Inc, Key Employees  20
Glossary  31
List of Figures
Theranos Inc Pipeline Products by Equipment Type  5
Theranos Inc Pipeline Products by Development Stage  9